Earnings summaries and quarterly performance for HilleVax.
Executive leadership at HilleVax.
Board of directors at HilleVax.
Research analysts covering HilleVax.
Recent press releases and 8-K filings for HLVX.
HilleVax, Inc. Completes Acquisition by XOMA Royalty Corporation
HLVX
M&A
Delisting/Listing Issues
Board Change
- HilleVax, Inc. (HLVX) completed its acquisition by XOMA Royalty Corporation on September 17, 2025, becoming a wholly-owned subsidiary.
- Shareholders received $1.95 in cash and one non-transferable contractual contingent value right (CVR) for each share.
- Trading of HLVX shares on The Nasdaq Global Select Market is expected to be suspended prior to the open of trading on September 17, 2025, with subsequent delisting and deregistration.
- All prior directors and key officers, including the Chairman, President, and CEO, and the CFO, ceased their roles in connection with the merger.
Sep 17, 2025, 1:24 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more